Please wait while the formulary information is being retrieved.
KERENDIA (finerenone)
- Chronic kidney disease associated with type 2 diabetes
10 mg tablet
- 1 tablet (10 mg) by oral route once daily
20 mg tablet
- 1 tablet (20 mg) by oral route once daily
Default screening record
- 1 tablet (10 mg) by oral route once daily
- 2 tablets (20 mg) by oral route once daily
- 1 tablet (20 mg) by oral route once daily
- Astagraf Xl
- cyclosporine
- cyclosporine modified
- Gengraf
- Hecoria
- Neoral
- Prograf
- Sandimmune
- tacrolimus
Contraindicated
- Aldactazide
- Aldactone
- Alka-seltzer Gold
- amiloride
- amiloride-hydrochlorothiazide
- Bactrim
- Bactrim Ds
- Ceralyte-70
- Ceraors 75
- Cerasport
- Cerasport Ex1
- Curad Enema
- Cytra K Crystals
- Cytra-3
- Cytra-k
- Disposable Enema
- DM-GG-potassium citrate
- Dyazide
- Dyrenium
- Effer-k
- Enema
- Enema Disposable
- Fleet Enema
- Fleet Enema Extra
- Fleet Pediatric
- Hyperlyte Cr
- K-effervescent
- K-tab
- Kaochlor
- Klor-con
- Klor-con 10
- Klor-con M10
- Klor-con M15
- Klor-con M20
- Klor-con/ef
- Maxzide
- Maxzide-25Mg
- Medi-lyte
- Nano Vm T/f
- Nutrilyte Ii
- Oral Saline Laxative
- Osmoprep
- Pedialyte
- Pediatric Electrolyte
- pediatric multivit #18-iron-FA
- PEG 3350-bowel 2,two part prep
- Phosphate Laxative
- pot & sod citrate-citric acid
- potassium
- potassium bicarb & chloride
- potassium bicarb-citric acid
- potassium chlorid-D5-0.45%NaCl
- potassium chloride
- potassium chloride in 0.9%NaCl
- potassium chloride in D5W
- potassium chloride in LR-D5
- potassium chloride-0.45 % NaCl
- potassium chloride-D5-0.2%NaCl
- potassium chloride-D5-0.3%NaCl
- potassium chloride-D5-0.9%NaCl
- potassium citrate
- potassium citrate-citric acid
- potassium Cl-calcium phos-mag
- potassium gluconate
- potassium phosphate dibasic
- Preparation Cleansing
- Primsol
- Ready-to-use Enema
- Reclast
- sod & pot chlorid-sod cit-rice
- sod phos mono-sod phos dibasic
- sodium & potassium bicarbonate
- sodium Cl-potassium chloride
- sodium phosphates
- sodium-K+-mag-Ca-chlor-acetate
- sodium-potas-chloride-dextrose
- Sorbutuss
- spironolacton-hydrochlorothiaz
- spironolactone
- Suclear
- sulfamethoxazole-trimethoprim
- Sulfatrim
- Taron-crystals
- Theralith Xr
- Thermotabs
- Tpn Electrolytes
- Tpn Electrolytes Ii
- triamterene
- triamterene-hydrochlorothiazid
- Tricitrates
- trimethoprim
- Urocit-k 10
- Urocit-k 15
- Urocit-k 5
- vit B6-mag cit & ox-potass cit
- zoledronic acid
- zoledronic acid-mannitol-water
- Zometa
Severe
Moderate
- Accupril
- Accuretic
- Aceon
- Altace
- amlodipine-benazepril
- amlodipine-olmesartan
- amlodipine-valsartan
- amlodipine-valsartan-hcthiazid
- Angeliq
- Atacand
- Atacand Hct
- Avalide
- Avapro
- azilsartan med-chlorthalidone
- azilsartan medoxomil
- Azor
- benazepril
- benazepril-hydrochlorothiazide
- Benicar
- Benicar Hct
- Beyaz
- candesartan
- candesartan-hydrochlorothiazid
- captopril
- captopril-hydrochlorothiazide
- Cozaar
- Diovan Hct
- drospirenone-e.estradiol-lm.FA
- drospirenone-estradiol
- drospirenone-ethinyl estradiol
- Edarbi
- Edarbyclor
- enalapril maleate
- enalapril-hydrochlorothiazide
- enalaprilat
- Epaned
- eprosartan
- eprosartan-hydrochlorothiazide
- Exforge
- Exforge Hct
- fosinopril
- fosinopril-hydrochlorothiazide
- Gianvi (28)
- Hyzaar
- irbesartan
- irbesartan-hydrochlorothiazide
- lisinopril
- lisinopril-hydrochlorothiazide
- lithium carbonate
- lithium citrate
- Lithobid
- Loryna (28)
- losartan
- losartan-hydrochlorothiazide
- Lotensin
- Lotrel
- Mavik
- Micardis
- Micardis Hct
- moexipril
- moexipril-hydrochlorothiazide
- Ocella
- olmesartan
- olmesartan-amlodipin-hcthiazid
- olmesartan-hydrochlorothiazide
- perindopril erbumine
- Prinivil
- quinapril
- quinapril-hydrochlorothiazide
- ramipril
- Safyral
- Syeda
- Tarka
- telmisartan
- telmisartan-amlodipine
- telmisartan-hydrochlorothiazid
- Teveten
- Teveten Hct
- trandolapril
- trandolapril-verapamil
- Tribenzor
- Twynsta
- Uniretic
- Univasc
- valsartan-hydrochlorothiazide
- Vaseretic
- Vasotec
- Vestura (28)
- Yasmin (28)
- Yaz 28
- Zarah
- Zestoretic
- Zestril
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Lactating mother
Contraindicated
- Chronic kidney disease stage 3A (moderate) GFR 45-59
- Chronic kidney disease stage 3B (moderate) GFR 30-44
- Hyperkalemia
Severe
Moderate
- Kidney disease with likely reduction in GFR
KERENDIA (finerenone)
- Chronic kidney disease associated with type 2 diabetes
- Hyperkalemia
- Hyponatremia
- Hypotension
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Finerenone
Safety and effectiveness not established in pediatric patients.
- 1 Day – 18 Years
- Safety and effectiveness not established in pediatric patients.
Finerenone
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
Finerenone
Mfg rec avoiding breastfeeding during treatment and for 1 day after last dose
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Mfg rec avoiding breastfeeding during treatment and for 1 day after last dose |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Chronic kidney disease associated with type 2 diabetes | |
| E11.22 | Type 2 diabetes mellitus with diabetic chronic kidney disease |
| 0-9 | A-Z |
|---|---|
| E11.22 | Type 2 diabetes mellitus with diabetic chronic kidney disease |
Formulary Reference Tool